OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Psychiatry is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	743
Error in Results	523
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	442
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	396
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	344
Assumptions and Limitations of the Synthetic Control Method	297
Diagnosing and Treating ADHD in Adults	245
Managerial and Organizational Challenges in the Age of AI	242
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	228
An Opportunity to Advance Cannabis Science—DEA Rescheduling	206
JAMA Psychiatry	203
The Reliability of Traumatic and Adverse Experiences	196
Potential Lessons for DSM From Contemporary Philosophy of Science	191
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	189
Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	181
Race and Ethnicity of Editorial Board Members and Editors as an Indicator of Structural Racism in Psychiatry and Neuroscience Journals	178
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	176
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	174
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	163
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	151
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	151
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	148
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	141
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	141
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	136

Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	133
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	129
JAMA Psychiatry	127
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	124
JAMA Network Call for Papers on Health and the 2024 US Election	113
Living Alone and Drug Overdose Deaths in the US	110
Errors in Figures 1 and 2	106
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	106
JAMA Psychiatry	105
Searching the Brain for the Cause of Psychosis	104
Addiction Medicine Physicians and Medicinal Cannabinoids	104
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	103
Hyperalgesia in Patients With a History of Opioid Use Disorder	101
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	100
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	96
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	95
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	94
Perinatal Mental Health Outcomes Following Natural Disasters	93
Error in Byline	91
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	88
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	86
JAMA Psychiatry	84
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	84
JAMA Psychiatry—The Year in Review, 2021	83
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	83
Associating Violence With Schizophrenia—Risks and Biases—Reply	83
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	82
Errors in Figures 3, 4, and 5	81
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents	81
Expanding Current Approaches to Solve the Opioid Crisis	81
Trends in Outpatient Psychotherapy Among Adults in the US	80
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study	79
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	77
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	76
JAMA Psychiatry	73
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies	73
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	72
Psychosis Spectrum Symptoms Before and After Adolescent Cannabis Use Initiation	71
Physician Suicide and Associated Features—What Defines a Physician?	70
Evaluation of a Model to Target High-risk Psychiatric Inpatients for an Intensive Postdischarge Suicide Prevention Intervention	70
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder	69
Sweetened Beverages and Incident All-Cause Dementia Among Older Adults	68